Cite

HARVARD Citation

    Maishi, N. et al. (2022). Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell‐specific liposomal siRNA delivery system. Cancer science. 113 (5), pp. 1855-1867. [Online]. 
  
Back to record